Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. natural killer cell
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Brands

  • medchemexpress
  • chimeric
  • multimmune
  • acrobiosystems
  • celularity
View all brands
Applications

  • Ativa - Diagnostic Workstation for Pharmacies and Retail Clinics
  • Ativa - Diagnostic Workstation for Emergency Departments
  • Ativa - Diagnostic Workstation for Primary Care
  • Ativa - Diagnostic Workstation for Covid-19
  • Solution for Clinical Trials
  • Solution for Access to Investigational Medicines

Natural Killer Cell Equipment & Supplies

116 equipment items found

Chimeric - Model CHM 0201 (CORE-NK PLATFORM) - Natural Killer Cells

Chimeric - Model CHM 0201 (CORE-NK PLATFORM) - Natural Killer Cells

by:Chimeric Therapeutics   based inCarlton South, AUSTRALIA
The CORE-NK platform is a transformative platform technology for Chimeric enabling the accelerated development of multiple next generation, off the shelf NK and CAR-NK products. Natural killer cells are found in our bodies naturally and are able to recognize and kill cancer cells – but are not robust and ...
CONTACT SUPPLIER

Nkarta - Allogeneic Natural Killer Cells

Nkarta - Allogeneic Natural Killer Cells

Manufactured by:Nkarta, Inc.   based inSouth San Francisco, CALIFORNIA (USA)
Cell therapy, a new approach that uses immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. First generation approaches have focused on T-cells, which have shown great promise in hematologic malignancies but are plagued with unwanted side effects and, to date, have not shown similar activity in solid tumors. Nkarta was founded to address these ...
CONTACT SUPPLIER

Chimeric - Model CHM 0301 - Natural Killer Cells for Derived Allogeneic Therapies

Chimeric - Model CHM 0301 - Natural Killer Cells for Derived Allogeneic Therapies

by:Chimeric Therapeutics   based inCarlton South, AUSTRALIA
The next generation CORE-NK platform will integrate additional activation and expansion features to further optimize the cancer-fighting power of the CORE-NK platform cells. Development of the next generation CORE-NK platform will be as a combination therapy for blood ...
CONTACT SUPPLIER

multimmune - Model ENKASTIM - Natural Killer (NK) Cells

multimmune - Model ENKASTIM - Natural Killer (NK) Cells

Manufactured by:multimmune GmbH   based inMunich, GERMANY
ENKASTIM is based on the activation of immune cells called natural killer (NK) cells that are major players in the body's first line of defense, also called innate immunity. The immune effector cells are activated ex vivo (outside the body; ENKASTIM-ev) or in vivo (inside the body; ...
CONTACT SUPPLIER

Model FT516 - Natural Killer (NK) Cell

Model FT516 - Natural Killer (NK) Cell

Manufactured by:Fate Therapeutics, Inc.   based inSan Diego, CALIFORNIA (USA)
NK cells play a major role in the anti-tumor efficacy of certain tumor-antigen targeting antibodies. NK cells express CD16, an activating receptor that binds to the Fc portion of IgG antibodies. Once activated through CD16, NK cells are able to destroy antibody-coated target cells and secrete cytokines, such as interferon gamma, to recruit and potentiate adaptive immune cells, including T cells. ...
CONTACT SUPPLIER

multimmune - Model ENKASTIM-iv - In vivo Stimulation of Natural Killer (NK) Cells

multimmune - Model ENKASTIM-iv - In vivo Stimulation of Natural Killer (NK) Cells

Manufactured by:multimmune GmbH   based inMunich, GERMANY
In vivo application of ENKASTIM-iv, an Hsp70-based GMP-grade synthetic peptide comprising 14 amino acids (14mer), results in a specific activation of NK cells which acquire the capacity to recognise and kill membrane Hsp70-positive tumors and ...
CONTACT SUPPLIER

Celularity - Model CYNK-001 - Placental-derived Natural Killer (PNK) Cells

Celularity - Model CYNK-001 - Placental-derived Natural Killer (PNK) Cells

Manufactured by:Celularity Inc.   based inFlorham Park, NEW JERSEY (USA)
CYNK-001 is the only cryopreserved, allogeneic, off-the-shelf, natural killer (NK) cell therapy being developed from placental hematopoietic stem cells as a potential treatment option for various hematologic cancers, solid tumors, and infectious disease. NK cells are a unique class of immune ...
CONTACT SUPPLIER

Off-the-Shelf Natural Killer (NK) Cells for Oncology

Off-the-Shelf Natural Killer (NK) Cells for Oncology

Manufactured by:Senti Biosciences   based inSouth San Francisco, CALIFORNIA (USA)
Natural Killer (NK) cells are essential components of the immune system, playing an important role in the body’s defensive response against tumors and infected cells. NK cells constantly patrol the body to detect and neutralize foreign cells. Senti Bio believes there are several advantages ...
CONTACT SUPPLIER

Celularity - Natural Killer Chimeric Antigen Receptor Cells

Celularity - Natural Killer Chimeric Antigen Receptor Cells

Manufactured by:Celularity Inc.   based inFlorham Park, NEW JERSEY (USA)
CYNK-CAR candidates are being developed as allogeneic, off-the-shelf approaches through gene modification of human placental hematopoietic stem cell-derived natural killer (NK) cells. Various CAR constructs against hematological and solid tumor targets are under pre-clinical ...
CONTACT SUPPLIER

Ativa - Diagnostic Workstation

Ativa - Diagnostic Workstation

Manufactured by:Ativa Medical   based inShoreview, MINNESOTA (USA)
Ativa's Diagnostic Workstation with a miniaturized flow-cytometer can measure the innate immune response cells in the blood. In COVID-19, Natural-Killer Cell activation occurs within hours of first infection, these cells fight the Virus in the lungs. Miniaturized low-cost diagnostic tests Immediate lab-quality ...
CONTACT SUPPLIER

MedChemExpress - Model Amivantamab - 2171511-58-1

MedChemExpress - Model Amivantamab - 2171511-58-1

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer ...
CONTACT SUPPLIER

Membrane Hsp70: Novel Biomarker

Membrane Hsp70: Novel Biomarker

Manufactured by:Alphageneron   based inCambridge, MASSACHUSETTS (USA)
Our lead clinical stage natural killer (NK) cell therapy, is an autologous platform technology that activates NK cells to kill cancers expressing a unique membrane form of Heat Shock Protein 70 ...
CONTACT SUPPLIER

Promega - Model 4-1BB - Immune Checkpoint Bioassays Cells

Promega - Model 4-1BB - Immune Checkpoint Bioassays Cells

Manufactured by:Promega Corporation   based inMadison, WISCONSIN (USA)
4-1BB (CD137/TNFRSF9), a member of the tumor necrosis factor receptor superfamily, is an inducible co-stimulatory receptor expressed on T cells, natural killer (NK) cells and innate immune cell populations. When present on the cell surface, 4-1BB interacts with 4-1BB ligand (4-1BBL) and induces ...
CONTACT SUPPLIER

Celyad - Model CYAD-101 - Allogeneic CAR T Candidate

Celyad - Model CYAD-101 - Allogeneic CAR T Candidate

Manufactured by:Celyad Oncology   based inMont-Saint-Guibert, BELGIUM
CYAD-101 is an investigational, non-gene edited allogeneic (from healthy donor derived) CAR T candidate engineered to co-express the chimeric antigen receptor based on NKG2D, a receptor expressed on natural killer (NK) cells that binds to eight stress-induced ligands (NKG2DL) expressed by a broad range of tumor cells and the ...
CONTACT SUPPLIER

Celyad - Model CYAD-02 - Autologous CAR T Candidate

Celyad - Model CYAD-02 - Autologous CAR T Candidate

Manufactured by:Celyad Oncology   based inMont-Saint-Guibert, BELGIUM
CYAD-02 is an investigational CAR T therapy that engineers an all-in-one vector approach in patient’s T cells to express both (i) the NKG2D chimeric antigen receptor, a receptor expressed on natural killer (NK) cells that binds to eight stress-induced ligands (NKG2DL) expressed on tumor cells, and (ii) ...
CONTACT SUPPLIER

CAR-NK - Cell Therapies for Solid Tumors

CAR-NK - Cell Therapies for Solid Tumors

by:Caribou Biosciences, Inc.   based inBerkeley, CALIFORNIA (USA)
Natural killer (NK) cells, as their name implies, play an important role in ridding the body of cancer and viruses. NK cells are emerging as an increasingly important cell type for therapeutic development. Solid tumors are particularly challenging to treat and CAR-T cells have largely ...
CONTACT SUPPLIER

Lava - Model 051 - Pipeline

Lava - Model 051 - Pipeline

Manufactured by:LAVA Therapeutics N.V.   based inUtrecht, NETHERLANDS
We have achieved preclinical proof-of-concept with LAVA-051 by demonstrating efficacy and safety in a variety of preclinical models. LAVA-051 uniquely activates both Vγ9Vδ2 T cells as well as invariant natural killer T cells, which represent another conserved immune effector cell population, in a ...
CONTACT SUPPLIER

NK-Cell Therapy

NK-Cell Therapy

Manufactured by:Kiadis Pharma NV   based inAmsterdam, NETHERLANDS
Ushering in the Future of NK-cell Therapy: Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these ...
CONTACT SUPPLIER

GENLISA - Human TNF-Alpha (Tumor Necrosis Factor Alpha) Elisa

GENLISA - Human TNF-Alpha (Tumor Necrosis Factor Alpha) Elisa

Manufactured by:Krishgen Biosystems    based inMumbai, INDIA
Tumor necrosis factor alpha (TNF ±) is a multifunctional cytokine secreted primarily by macrophages, natural killer (NK) cells, and lymphocytes.The main function of TNF Alpha is to regulate the immune cells. It has the ability to induce a fever, speed up cell death, create inflammation etc. It stimulates ...
CONTACT SUPPLIER

Chimeric - Model CHM 1301 (CLTX CAR NK) - NK Cell Derived Allogeneic Therapies

Chimeric - Model CHM 1301 (CLTX CAR NK) - NK Cell Derived Allogeneic Therapies

by:Chimeric Therapeutics   based inCarlton South, AUSTRALIA
CHM 1301 (CLTX CAR NK) will be developed on the next generation CORE-NK platform leveraging our CLTX Chimeric Antigen ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT